首页> 外国专利> Use of ramipril or pharmaceutical salt thereof for the preparation of a medicament for the prevention or reduction of a cardiovascular event in high risk patients with no evidence of left ventricular dysfunction

Use of ramipril or pharmaceutical salt thereof for the preparation of a medicament for the prevention or reduction of a cardiovascular event in high risk patients with no evidence of left ventricular dysfunction

机译：雷米普利或其药用盐在制备用于预防或减少无左心功能不全证据的高危患者中心血管事件的药物中的用途

页面导航

摘要
著录项
相似文献

摘要

Use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with an other antihypertensive, a cholesterol lowering agent, a diuretic or aspirin, in the manufacture of a medicament for the prevention of cardiovascular events; a method of preventing cardiovascular events comprising administering to a patient in need of such prevention an effective amount of an inhibitor of the renin angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with an other antihypertensive, a cholesterol lowering agent, a diuretic or aspirin; and a combination product containing an an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof and a cholesterol lowering agent.

机译：肾素-血管紧张素系统的抑制剂或其药学上可接受的衍生物，任选地与其他抗高血压药，胆固醇降低剂，利尿剂或阿司匹林一起在制备用于预防心血管事件的药物中的用途;一种预防心血管事件的方法，该方法包括向需要这种预防的患者给药有效量的肾素血管紧张素系统抑制剂或其药学上可接受的衍生物，以及其他抗高血压药，胆固醇降低剂，利尿剂或阿司匹林;含有肾素-血管紧张素系统抑制剂或其药学上可接受的衍生物和胆固醇降低剂的组合产品。

著录项

公开/公告号IL148127A

专利类型
公开/公告日2015-07-30

原文格式PDF
申请/专利权人 SANOFI-AVENTIS DEUTSCHLAND GMBH;
展开▼

申请/专利号IL20020148127
发明设计人
展开▼

申请日2002-02-12
分类号A61K;A61K45;A61K31;A61K31/216;A61K31/355;A61K31/401;A61K31/403;A61K31/404;A61K31/41;A61K31/4166;A61K31/4174;A61K31/4178;A61K31/4184;A61K31/472;A61K31/519;A61K31/55;A61K31/551;A61K31/554;A61K31/612;A61K31/616;A61K31/675;A61K45/06;A61P;A61P3/10;A61P9/04;A61P9/08;A61P9/10;C07D;
国家 IL
入库时间 2022-08-21 15:15:23

相似文献

专利
外文文献
中文文献